Cargando…

Are Endocan Plasma Levels Altered in Preeclampsia?

Detalles Bibliográficos
Autores principales:	Lopes, Ana Cristina dos Santos, Martins, Suellen Rodrigues, Dusse, Luci Maria SantAna, Pinheiro, Melina de Barros, Alpoim, Patrícia Nessralla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Revinter Publicações Ltda. 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183914/ https://www.ncbi.nlm.nih.gov/pubmed/33860506 http://dx.doi.org/10.1055/s-0041-1728661

Ejemplares similares

Hemostatic Parameters according to Renal Function and Time after Transplantation in Brazilian Renal Transplanted Patients
por: Mota, Ana Paula Lucas, et al.
Publicado: (2015)

Clinical Features and Maternal-fetal Results of Pregnant Women in COVID-19 Times
por: Godoi, Ana Paula Nogueira, et al.
Publicado: (2021)

Circulating endocan and preeclampsia: a meta-analysis
por: Lan, Xia, et al.
Publicado: (2020)

Soluble Endoglin, Transforming Growth Factor-Beta 1 and Soluble Tumor Necrosis Factor Alpha Receptors in Different Clinical Manifestations of Preeclampsia
por: Perucci, Luiza O., et al.
Publicado: (2014)

Negative Correlation between Placental Growth Factor and Endocan-1 in Women with Preeclampsia
por: Hentschke, Marta Ribeiro, et al.
Publicado: (2018)

Cytokine Signature in End-Stage Renal Disease Patients on Hemodialysis
por: Rios, Danyelle Romana Alves, et al.
Publicado: (2017)

Plasma endocan level and prognosis of immunoglobulin A nephropathy
por: Lee, Yu Ho, et al.
Publicado: (2016)

Endocan and Erectile Dysfunction
por: Balta, Sevket, et al.
Publicado: (2019)

Dangerous universal donors: the reality of the Hemocentro in Belo Horizonte, Minas Gerais
por: Godin, Mariana Martins, et al.
Publicado: (2016)

Plasma Endocan as a Biomarker of Thrombotic Events in COVID-19 Patients
por: Chenevier-Gobeaux, Camille, et al.
Publicado: (2022)

What applications for plasma endocan measurement in intensive care? A clarification
por: Dubar, Victoria, et al.
Publicado: (2023)

The Role of Endocan in Cardiometabolic Disorders
por: Klisic, Aleksandra, et al.
Publicado: (2023)

Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes
por: Adekola, Henry, et al.
Publicado: (2015)

Resistance of dialyzed patients to erythropoietin
por: Alves, Michelle Teodoro, et al.
Publicado: (2015)

Economy class syndrome: what is it and who are the individuals at risk?
por: Dusse, Luci Maria SantAna, et al.
Publicado: (2017)

Is endocan a novel potential biomarker of liver steatosis and fibrosis?
por: Klisić, Aleksandra, et al.
Publicado: (2020)

Characteristics of Serum Endocan Levels in Infection
por: Seo, Kazunori, et al.
Publicado: (2015)

Endocan: A novel circulating proteoglycan
por: Kali, Arunava, et al.
Publicado: (2014)

Expressions of Endocan in Patients with Meningiomas and Gliomas
por: Atukeren, Pinar, et al.
Publicado: (2016)

Endocan and the respiratory system: a review
por: Kechagia, Maria, et al.
Publicado: (2016)

The Role of Endocan in Selected Kidney Diseases
por: Nalewajska, Magdalena, et al.
Publicado: (2020)

0730. Plasma endocan levels are associated with endothelial dysfunction during experimental human endotoxemia
por: van Eijk, LT, et al.
Publicado: (2014)

Serum Endocan Levels in Children with Febrile Neutropenia
por: Kiral, Eylem, et al.
Publicado: (2016)

Serum endocan levels in patients with stable COPD
por: Pihtili, Aylin, et al.
Publicado: (2018)

Effects of intermittent hemodialysis on plasmatic levels of endocan
por: Hureau, Maxence, et al.
Publicado: (2021)

Endocan: A Key Player of Cardiovascular Disease
por: Chen, Jinzhi, et al.
Publicado: (2022)

Prognostic and Diagnostic Value of Endocan in Kidney Diseases
por: Samouilidou, Elisabeth, et al.
Publicado: (2022)

Endocan-microvascular Density in Primary Ovarian Carcinoma
por: Baba, Farahlina, et al.
Publicado: (2022)

Plasma Endocan as a Predictor of Cardiovascular Event in Patients with End-Stage Renal Disease on Hemodialysis
por: Kim, Jin Sug, et al.
Publicado: (2020)

Influence of ACE I/D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor β1 in Patients Undergoing Hemodialysis
por: de Carvalho, Sara Santos, et al.
Publicado: (2016)

Evaluation of Endocan as a Treatment for Acute Inflammatory Respiratory Failure
por: Hureau, Maxence, et al.
Publicado: (2023)

Serum endocan levels in relation to traditional and non-traditional anthropometric indices in adult population
por: Klisić, Aleksandra, et al.
Publicado: (2021)

Immunolocalization of endocan during the endothelial-mesenchymal transition process
por: Carrillo, L.M., et al.
Publicado: (2011)

Serum endocan levels in women with restless legs syndrome
por: Celik, Kenan, et al.
Publicado: (2015)

Endocan silencing induces programmed cell death in hepatocarcinoma
por: Yang, Jinghui, et al.
Publicado: (2017)

Endocan, sepsis, pneumonia, and acute respiratory distress syndrome
por: De Freitas Caires, Nathalie, et al.
Publicado: (2018)

Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome
por: Erman, Hande, et al.
Publicado: (2020)

Endocan in Acute Leukemia: Current Knowledge and Future Perspectives
por: Reikvam, Håkon, et al.
Publicado: (2022)

Serum Endocan Levels and Subclinical Atherosclerosis in Behçet’s Syndrome
por: Nassef, Eman Mostafa, et al.
Publicado: (2022)

Preeclampsia
por: Ramos, José Geraldo Lopes, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nh3epg6th5qq9v7ls792ls6oil